Inhibitors of the HIV integrase enzyme
US7468375B2 · kind B2 · utility
12Cited by
11References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2005 |
| Grant date | Dec 23, 2008 |
| Priority date | — |
| Expiry date | Aug 8, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts and solvates thereof, their synthesis, and their use as modulators or inhibitors of the human immunodeficiency virus (“HIV”) integrase enzyme.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.